bioRxiv/medRxiv TRiP Review Activity

428 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 24: Articles 231-240  | Next

Mutant SF3B1 promotes PDAC malignancy through TGF-β resistance
Simmler, P., Mengis, T., Van-Lehmann, K., Khales, A., Thomas, T., Rätsch, G., Stoffel, M., Schwank, G.
10.1101/2022.06.16.496393 — Posted: 2022-06-19 — Discussion: 2023-07-04  eLife
Fra1 is required for TGFβ1 induced collective invasion
Camacho, S., Nasir, A., Rahhal, R., Dominguez, M., Pearson, G. W.
10.1101/2020.11.14.383232 — Posted: 2020-11-15 — Discussion: 2023-06-29  eLife
Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer development
Nameki, R., Chang, H., Yu, P. H., Abbasi, F., Lin, X., Reddy, J., Haro, M., Fonseca, M., Freedman, M. L., Drapkin, R., Corona, R., Lawrenson, K.
10.1101/2023.04.11.536378 — Posted: 2023-04-12 — Discussion: 2023-06-21  eLife
Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma
Croft, W., Pearce, H., Margielewska-Davies, S., Lim, L., Nicol, S. M., Zayou, F., Blakeway, D., Marcon, F., Powell-Brett, S., Mahon, B., Merard, R., Zuo, J., Middleton, G., Roberts, K., Brown, R. M., Moss, P.
10.1101/2023.01.20.524883 — Posted: 2023-01-21 — Discussion: 2023-06-17  eLife
Highly multiplexed quantitative phosphosite assay for biology and preclinical studies
Keshishian, H., McDonald, E. R., Melanson, R., Porter, D. A., Mundth, F., Krug, K., Wallace, L., Forestier, D., Rabasha, B., Marlow, S. E., Jane-Valbuena, J., Todres, E., Specht, H., Golji, J., Kuhn, E., Burgess, M., MacMullan, M., Satpathy, S., Mani, D. R., Gillette, M., Clauser, K., Rejtar, T., Wang, K., Garraway, L. A., Sellers, W. R., Carr, S. A.
10.1101/2020.12.08.415281 — Posted: 2020-12-09 — Discussion: 2023-06-10  EMBO Press
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma
Finotto, L., Cole, B., Giese, W., Baumann, E., Claeys, A., Vanmechelen, M., Decraene, B., Derweduwe, M., Dubroja Lakic, N., Shankar, G., Nagathihalli Kantharaju, M., Albrecht, J. P., Geudens, I., Stanchi, F., Ligon, K. L., Boeckx, B., Lambrechts, D., Harrington, K., Van Den Bosch, L., De Vleeschouwer, S., De Smet, F., Gerhardt, H.
10.1101/2023.04.27.538517 — Posted: 2023-05-01 — Discussion: 2023-06-09  Review Commons
RAS and PP2A activities converge on epigenetic gene regulation
Aakula, A., Sharma, M., Tabaro, F., Honkanen, H., Schapira, M., Arrowsmith, C., Nykter, M., Westermarck, J.
10.1101/2022.05.11.491459 — Posted: 2022-05-12 — Discussion: 2023-05-26  EMBO Press
Cancers adapt to their mutational load by buffering protein misfolding stress
Tilk, S., Frydman, J., Curtis, C., Petrov, D.
10.1101/2022.06.08.495407 — Posted: 2022-06-10 — Discussion: 2023-05-22  eLife
ROR1 plays a critical role in pancreatic tumor-initiating cells with a partial EMT signature.
Yamazaki, M., Hino, S., Usuki, S., Miyazaki, Y., Oda, T., Nakao, M., Ito, T., Yamagata, K.
10.1101/2022.07.13.499868 — Posted: 2022-07-14 — Discussion: 2023-05-19  EMBO Press
MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer
Soto-Feliciano, Y. M., Zhu, C., Morris, J. P., Huang, C.-h., Koche, R. P., Ho, Y.-j., Banito, A., Chen, C.-w., Shroff, A., Tian, S., Geulah, L., Chen, C.-c., Fennell, M., Armstrong, S., Allis, C. D., Tschaharganeh, D., Lowe, S. W.
10.1101/2022.06.07.495174 — Posted: 2022-06-09 — Discussion: 2023-05-10  eLife

Evaluation Sources